$ARDS is working with MIT and Harvard researchers on big advancements in infection control: "CRISPR Gene Editing Technology from MIT and Harvard Phase 3: Aridis Pharmaceuticals"
June 10, 2021
Click here:
https://www.einpresswire.com/article/54343111...asdaq-ards